Discovery and reporting of clinically-relevant germline variants in advanced cancer patients assessed using whole-exome sequencingTuo Zhang, Olivier Elemento, Alessandro Romanel et al.|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 2
CDC6 as a pan-cancer immunological and prognostic biomarker and its role in suppressing melanoma malignancyLijun Mo, Yaohua Xue, Zhida Mai et al.|BMC Cancer|2025Cited by 1